In this episode of Living Hope, we sit down with Dr. Andrew Rakeman, Vice President of Research at the Lustgarten Foundation, who leads the Foundation’s efforts to advance early detection, prevention, and treatment with the goal of making pancreatic cancer a curable disease. Dr. Rakeman breaks down key developments in the field, including the emerging link between new-onset diabetes and pancreatic cancer, reasons behind long-term recurrence, the status of cancer vaccines, innovations in immunotherapy, strategies to overcome the tumor’s dense barrier, and new progress in KRAS-targeted therapies. He closes with an inspiring message of hope, highlighting why this is one of the most promising and transformative moments in pancreatic cancer research—and what it means for survivors, patients, families, and the future ahead. "As long as you speak my name, I shall live forever," is dedicated to Wes Semple #PancreaticCancerAwareness #LivingHopePodcast #LustgartenFoundation